Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.100 |
None |
0.960 |
25 |
|
2009 |
2019 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.100 |
None |
0.960 |
25 |
|
2009 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
11 |
|
2009 |
2019 |
Myopathy
|
group |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
634
|
166
|
0.060 |
None |
1.000 |
6 |
|
2012 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2018 |
2019 |
Soft Tissue Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
145
|
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2014 |
Sarcoma of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
258
|
6
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2016 |
Congenital Abnormality
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
1098
|
73
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Herpesviridae Infections
|
group |
Infections
|
Disease or Syndrome
|
62
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms, Vascular Tissue
|
group |
Neoplasms
|
Neoplastic Process
|
67
|
1
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neuromuscular Diseases
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
171
|
50
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Virus Diseases
|
group |
Infections
|
Disease or Syndrome
|
1471
|
42
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Atrophic condition of skin
|
group |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
111
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Vascular Neoplasms
|
group |
Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
15
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Muscle damage
|
phenotype |
|
Acquired Abnormality
|
163
|
4
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2019 |
Paresis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
216
|
49
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Generalized muscle wasting
|
phenotype |
|
Sign or Symptom
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Lordosis
|
phenotype |
Musculoskeletal Diseases
|
Disease or Syndrome
|
160
|
15
|
0.100 |
None |
|
0 |
|
|
|
Edema of eyelid
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Eye Diseases; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
22
|
1
|
0.100 |
None |
|
0 |
|
|
|
Creatine phosphokinase serum increased
|
phenotype |
|
Finding
|
228
|
43
|
0.100 |
None |
|
0 |
|
|
|
Mask-like facies
|
phenotype |
Nervous System Diseases
|
Finding
|
64
|
2
|
0.100 |
None |
|
0 |
|
|
|
Electromyogram abnormal
|
phenotype |
|
Finding
|
130
|
12
|
0.100 |
None |
|
0 |
|
|
|